CClinicalTrials.gg
CompletedNCT01564394Updated Dec 8, 2015Results posted

Body Mind Training Project

An interventional study of Qigong and Non-aerobic stretching in Cancer Related Fatigue, sponsored by University of Utah. Completed at 2 sites in United States. Open to participants aged 55 Years to 99 Years. Per ClinicalTrials.gov, last updated 2015-12-08.

Sponsored by University of Utah · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
55 Years to 99 Years
Sex
All
01

Study summary

Aim 1: Assess the feasibility, safety and efficacy of a Qigong intervention in elderly prostate cancer survivors.

Describe participation, retention, and adherence rates and assess reasons for participation, attrition, and non-adherence.

Identify effective recruitment and retention strategies. Ascertain participants' level of satisfaction and additional perceptions of the experimental and control interventions, perceived study burden, study design, and implementation.

Aim 2: Provide preliminary data on potential effects of Qigong vs. non-aerobic stretching exercises on fatigue, psychosocial outcomes, and health-related quality of life in preparation for a future R01 application for a larger, definitive randomized controlled trial. Hypothesis: Qigong participants will have improved fatigue levels, quality of life, and related psychosocial and health outcomes compared to those randomized to the non-aerobic stretching group.

Read the detailed description

This ongoing feasibility study is a two-armed, parallel group, randomized clinical trial.We will recruit 60 elderly prostate cancer survivors (age 55+ years) and their significant others (spouse, domestic partner, or close family member).

Considering literature attesting to strains associated with caregiver status, we will also collect survey and physical assessment data to explore the intervention's effect on significant others.

Recruitment occurs through Huntsman Cancer Institute's outpatient clinic and University and community-based strategies (for example, newspaper ads, flyers, support groups, patient registries).

We will measure relevant psychosocial measures, including fatigue and quality of life (SF36 \& EPIC), perceived stress, distress, mood, cognitive function, social connectedness, demographics, and leisure time, at baseline, the six-week midpoint, and one week post-intervention. Weekly measures of fatigue and quality of life and physical activity logs will also be administered.

Biometric assessments, including balance and mobility, flexibility, blood pressure, resting heart rate, body mass index, and waist-hip-ratio, will be done at baseline (before randomization) and one week post-intervention.

Significant others will undergo the same survey measures as the prostate cancer survivors, except for measures specific to prostate cancer (e.g., EPIC-26-short form).

Participants will be recruited in two cohorts, one beginning early March and the other early June, 2012. The twice-weekly exercise classes will be 60 minutes in duration, running for 12 weeks. Classes will be conducted at Huntsman Cancer Institute's Survivor \& Wellness Center, beginning one week after baseline physical assessments. Participants will receive a DVD of the respective class led by trained and qualified instructors so they can supplement classes with home-based sessions.

Qigong class will consist of postures, movements, deep breathing techniques, and meditation, including an emphasis on weight shifting, breath, and posture control.

Non-aerobic stretching will consist of light stretching exercises that avoid focus on meditation. This class will serve as the control group for non-specific factors such as attention dose and the group setting.

To ensure consistency of physical intensity between the two study arms, both objective (heart rate monitors) and subjective (self-reported ten-point Borg scale) measures will be performed on participants.

02

Conditions studied

  • Cancer Related Fatigue

Browse trials for

Keywords

  • qigong
  • mindfulness meditation
  • fatigue
  • prostate cancer
03

In context

Fatigue

1,860 studies on the registry are indexed under Fatigue; 376 are open to participants now.

This study's enrollment of 60 is above the median of 54 across 1,440 interventional studies indexed under Fatigue.

Browse Fatigue studies →

Lead sponsor

University of Utah is the lead sponsor of 969 studies on the registry; 178 are open to participants now.

Of its 107 completed or terminated interventional studies of FDA-regulated products, 62 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Significant fatigue as assessed during screening with the NCI Common Terminology Criteria for Adverse Events (CTCAE) Safety Profiler of fatigue using a cut-off value of ≥ 1; and/or with a fatigue grading scale (general questions that assess level of fatigue currently and in the past week from a scale of 0-100) with a cut off value of >20
  • Are sedentary as defined by \<150 minutes of mild, moderate, or intense intensity exercise/week per Centers for Disease Control and Prevention(CDC) guidelines
  • Able to speak and read English fluently, and understand informed consent
  • Reside within 60 miles of Huntsman Cancer Institute and have access to regular transportation to all assessments and intervention classes at HCI
  • Willing to: sign a medical record release form; be randomized and willing to participate in classes and all baseline and follow-up appointments
  • Significant others and domestic partners of elderly prostate cancer survivors will be eligible if they are at least 18 years of age, read and speak English, willing to sign an informed consent, and provide a physician's release for exercise

Exclusion criteria

Exclusion Criteria:

  • Clinical evidence of metastatic disease other than elevated prostate-antigen specific (PSA) levels
  • Current practice of Qigong, Tai Chi or other similar types of Complementary and Alternative medicine that may share similar principles of Qigong
  • Inability to pass the Folstein Mini Mental Status Exam (score \<23)
  • Unable to drive or secure transportation to complete all aspects of the study
  • Health conditions (e.g. severe hearing loss, respiratory, cardiovascular, or neurological problems) that might interfere with the required intervention
  • Unwilling to be randomized to study groups and/or commit to 12 weeks of Qigong or non-aerobic stretching classes
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Qigong

    Qigong originated in China hundreds of years ago and has been practiced for centuries. It consists of a sequence of slow, flowing physical movements with concentration on the breath and awareness and may promote physical and mental relaxation and energy balance.

    Behavioral: Qigong

  • Sham comparator
    Stretching control

    The non-aerobic stretching will serve as an attention control group to control for non-specific factors; dose of attention and to mimic being in a group setting.

    Behavioral: Non-aerobic stretching

Interventions

  • BehavioralQigong

    Classes will be 60 minutes in duration, held two times a week, supplemented with home-based sessions over 12 weeks. The classes will be led by a trained Qigong instructor and consist of postures, movements, deep breathing techniques and meditation. It will include eccentrically-biased Qigong movements with an emphasis on weight shifting and posture control. The continuous body movements coupled with progressively diminishing base of support, dynamic challenge to balance, and concentration on body positions requiring eccentric muscle activity should improve the levels of fatigue and quality of life in older prostate cancer survivors.

  • BehavioralNon-aerobic stretching

    The non-aerobic stretching classes will serve as an attention control. They will be 60 minutes in duration, held two times a week, supplemented with home-based sessions over 12 weeks. They will be led by an Huntsman Cancer Institute (HCI) fitness specialist and will consist of light stretching exercises; while avoiding a focus on meditation.

06

What researchers measure

Primary outcomes

  1. Retention Rate in Study (Feasibility Outcome)

    The retention rate was the proportion of participants who remained enrolled in the study and completed post-intervention measures. Range of retention rate is 0 to 1. Prostate cancer survivors were the population targeted in this intervention, therefore, the retention and attendance rates only include prostate cancer survivors (i.e., family members were not included in these calculations).

    Time frame: 13-weeks

  2. Attendance Rates in Study (Feasibility Outcome)

    The class attendance rates were the number of classes attended by participants divided by the total number of classes offered. Range of attendance rate is 0 to 1. Prostate cancer survivors were the population targeted in this intervention, therefore, the retention and attendance rates only include prostate cancer survivors (i.e., family members were not included in these calculations).

    Time frame: 13-weeks

  3. FACIT-Fatigue Change From Baseline to 13-weeks.

    Our primary outcome of change in fatigue was assessed with the Functional Assessment Chronic Illness Therapy (FACIT)-Fatigue scale. This 13-item scale assesses levels of fatigue during daily activities over the past seven days. Higher scores indicate less fatigue (score range = 0 - 52). Positive change scores indicate improved fatigue.

    Time frame: Baseline to 13-weeks

Secondary outcomes

  1. Brief Symptom Inventory (BSI)-18 Change From Baseline to 13-weeks

    The BSI-18 assesses global distress and three subscales (anxiety, depression, \& somatization). Scores are converted to T-scores based on US population norms. Negative change scores indicate improvement in distress. We report data separately for prostate cancer survivors and family members. Based on the population norm a T-score of 63 or above indicates heightened global distress.

    Time frame: Baseline to 13-weeks

07

Results

Posted Aug 19, 2015

Participant flow

We recruited 502 senior prostate cancer survivors in Utah through clinic referrals, registries, community advertisements, and community-based support groups.

Participant flow — Overall Study
MilestoneQigongStretching Control
Started3030
Completed2420
Not completed610
Withdrew: Withdrawal by subject610

Outcome measures

SecondaryBrief Symptom Inventory (BSI)-18 Change From Baseline to 13-weeks

The BSI-18 assesses global distress and three subscales (anxiety, depression, \& somatization). Scores are converted to T-scores based on US population norms. Negative change scores indicate improvement in distress. We report data separately for prostate cancer survivors and family members. Based on the population norm a T-score of 63 or above indicates heightened global distress.

Time frame:
Baseline to 13-weeks
Reported as:
Median · T-Score
Brief Symptom Inventory (BSI)-18 Change From Baseline to 13-weeks
T-ScoreQigongStretching Control
Prostate Cancer Survivors Global Index Change-7.0 (-12.0 to -3.2)0.0 (-4.0 to 1.5)
Prostate Cancer Survivors Anxiety Change-7.5 (-8.0 to 0.0)0.0 (0.0 to 7.5)
Prostate Cancer Survivors Somatization Change-6.5 (-10.7 to -0.2)0.0 (-4.0 to 2.0)
Prostate Cancer Survivors Depression Change-6.5 (-12.0 to 0.0)0.0 (-6.5 to 0.5)
Family Member Global Index Change-3.5 (-7.7 to 0.0)-2.0 (-13.0 to 3.0)
Family Member Anxiety Change-1.0 (-3.7 to 0.0)-7.0 (-8.0 to 0.0)
Family Member Somatization Change0.0 (-6.7 to 0.0)0.0 (-6.0 to 7.0)
Family Member Depression Change-5.0 (-6.7 to 0.0)-3.0 (-10.0 to 0.0)
PrimaryRetention Rate in Study (Feasibility Outcome)

The retention rate was the proportion of participants who remained enrolled in the study and completed post-intervention measures. Range of retention rate is 0 to 1. Prostate cancer survivors were the population targeted in this intervention, therefore, the retention and attendance rates only include prostate cancer survivors (i.e., family members were not included in these calculations).

Time frame:
13-weeks
Reported as:
Number · proportion of participants
Retention Rate in Study (Feasibility Outcome)
proportion of participantsQigongStretching Control
Retention Rate in Study (Feasibility Outcome)0.800.65
PrimaryAttendance Rates in Study (Feasibility Outcome)

The class attendance rates were the number of classes attended by participants divided by the total number of classes offered. Range of attendance rate is 0 to 1. Prostate cancer survivors were the population targeted in this intervention, therefore, the retention and attendance rates only include prostate cancer survivors (i.e., family members were not included in these calculations).

Time frame:
13-weeks
Reported as:
Number · Proportion of classes
Attendance Rates in Study (Feasibility Outcome)
Proportion of classesQigongStretching Control
Attendance Rates in Study (Feasibility Outcome)0.850.68
PrimaryFACIT-Fatigue Change From Baseline to 13-weeks.

Our primary outcome of change in fatigue was assessed with the Functional Assessment Chronic Illness Therapy (FACIT)-Fatigue scale. This 13-item scale assesses levels of fatigue during daily activities over the past seven days. Higher scores indicate less fatigue (score range = 0 - 52). Positive change scores indicate improved fatigue.

Time frame:
Baseline to 13-weeks
Reported as:
Median · Units on scale
FACIT-Fatigue Change From Baseline to 13-weeks.
Units on scaleQigongStretching Control
Prostate Cancer Survivor FACIT-Fatigue Change5.0 (2.0 to 12.7)0.0 (-5.5 to 4.5)
Family Member FACIT-Fatigue Change2.5 (-0.7 to 6.0)0.0 (-2.0 to 5.0)

Adverse events

Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Qigong—0/30 (0%)0/30 (0%)
Stretching Control—0/30 (0%)0/30 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)QigongStretching ControlTotal
<=18 years000
Between 18 and 65 years7916
>=65 years232144
Age, Continuous
Age, Continuous(years)QigongStretching ControlTotal
Mean71.3 ± 9.671.2 ± 10.171.2 ± 9.7
Sex: Female, Male
Sex: Female, Male(Participants)QigongStretching ControlTotal
Female10919
Male202141
Region of Enrollment
Region of Enrollment(participants)QigongStretching ControlTotal
United States303060
08

Study locations

2 sites
  • Huntsman Cancer Institute
    Salt Lake City, Utah 84112, United States
  • University of Utah
    Salt Lake City, Utah 84112, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 8, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01564394
Lead sponsor
University of Utah
Responsible party
Anita Kinney (Jon & Karen Huntsman Presidential Professor in Cancer Research, University of Utah) — Principal investigator
First posted
Mar 27, 2012
Start date
Oct 2011
Primary completion
Sep 2012
Completion
Sep 2012
Results posted
Aug 19, 2015
Last update
Dec 8, 2015

Study contacts

Anita Kinney, RN, PhD
principal investigator · Huntsman Cancer Institute/ University of Utah

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion